Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of Washington's demand for sensitive biological samples.
This move was revealed after a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government representative has since stated that the US was requesting genetic material for research and commercial purposes but was not willing to share the resulting advantages from future treatments.
"We must now begin the challenging and unfortunate task of ending our health assistance in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more dialogue to find a deal suitable to all parties so the nation's critical HIV programme can proceed.
Broader Implications
Zimbabwe's decision follows a comparable case in Kenya, where a court suspended a related deal with the US after concerns were filed about the security of Kenyans' medical information.
After returning to office last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government deals to enhance openness and accountability.
As per reports, 16 African countries have to date signed similar health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Declined Deal
This assistance for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through American-funded initiatives," the Ambassador added.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to provide its genetic material and health information for a long time, with no equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," his statement read.
"Effectively, our nation would provide the raw materials for medical research without any certainty that the end products would be accessible to our population should a new health crisis arise."
National Interest and Global Health
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks already set up via the international organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.
"This framework is designed to guarantee that when a country contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."
The government's concerns regarding the US deal "are not meant as anti-American sentiment," he added.
"We encourage ongoing dialogue with our American counterparts on how future co-operation might be designed in a manner that respects the sovereignty and interests of both nations."
Health Experts Response
A leading public health body said it acknowledged the government's concerns, but urged that talks need to persist since a large portion of the nation's Aids initiatives were funded by foreign aid.
"Where technical issues exist, such as those relating to information security or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," it added.
The situation emphasises the ongoing debate between receiving vital foreign assistance and safeguarding local interests in an increasingly interconnected world.